Redhill Biopharma
RDHL
#11160
Rank
C$3.58 M
Marketcap
C$0.40
Share price
-13.08%
Change (1 day)
-72.50%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): C-$907.70

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is C-$1,004. In 2017 the company made an earnings per share (EPS) of C-$3,585 a decrease over its 2016 EPS that were of C-$3,155.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$907.70
2017C-$3,58513.64%
2016C-$3,1559.12%
2015C-$2,89168.01%
2014C-$1,721-25.93%
2013C-$2,323

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$2.84-100.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$1.42-100.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.13-100.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$0.65-100.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
C$1.75-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel